Suzuki Yuya, Otsuka Tadashi, Takahashi Yusuke, Maruyama Shingo, Annenkov Alexey, Kanda Yasuhiro, Katakai Tomoya, Watanabe Hirofumi, Ohashi Riuko, Kaneko Yoshikatsu, Narita Ichiei
Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Histopathology Core Facility, Faculty of Medicine, Niigata University, Niigata, Japan.
Nephrol Dial Transplant. 2025 Jun 30;40(7):1310-1321. doi: 10.1093/ndt/gfae269.
Activated macrophages, pivotal for driving the immune response in sepsis, express high levels of CD38. Although the circulating levels of its ligand, CD31, increase in sepsis, the functions of CD38 and its ligation remain elusive. This study aimed to elucidate the impact of CD38 ligation on sepsis using single-cell and single-nucleus RNA sequencing (scRNA-seq and snRNA-seq, respectively) to identify a novel therapeutic target for severe sepsis.
We performed scRNA-seq analysis of mouse peritoneal immune cells to precisely identify cell types exhibiting increased CD38 expression upon exposure to lipopolysaccharide (LPS). Subsequently we induced CD38 ligation using a well-established agonistic anti-CD38 antibody in a mouse model of LPS-induced sepsis. We analysed its pathophysiological effects using kidney snRNA-seq. Finally, we performed histological analysis of septic tissues collected from patients to ensure consistency of our findings between mice and humans.
LPS stimulation upregulated CD38 expression in peritoneal macrophages. CD38 ligation significantly exacerbated LPS-induced inflammation in vivo, particularly in the kidneys. Kidney snRNA-seq analysis revealed that CD38 ligation induced interleukin (IL)-6 production in renal stromal cells via nicotinamide phosphoribosyltransferase (NAMPT) signalling originating from CD38-positive macrophages. NAMPT inhibition significantly ameliorated LPS-induced IL-6 production and kidney injury. Histological analysis of human septic tissues demonstrated upregulation of IL6 messenger RNA and NAMPT in renal stromal cells and CD38-positive macrophages, respectively.
Our findings elucidate the implications of CD38 ligation in an LPS-induced sepsis model and uncover shared signalling pathways between mice and human sepsis. NAMPT signalling identified in this study may be a novel therapeutic target for mitigating systemic inflammation and kidney injury associated with severe sepsis.
活化巨噬细胞在脓毒症免疫反应中起关键作用,其CD38表达水平较高。虽然其配体CD31的循环水平在脓毒症中升高,但CD38及其连接的功能仍不清楚。本研究旨在通过单细胞和单核RNA测序(分别为scRNA-seq和snRNA-seq)阐明CD38连接对脓毒症的影响,以确定重症脓毒症的新治疗靶点。
我们对小鼠腹腔免疫细胞进行scRNA-seq分析,以精确识别暴露于脂多糖(LPS)后CD38表达增加的细胞类型。随后,我们在LPS诱导的脓毒症小鼠模型中使用成熟的抗CD38激动性抗体诱导CD38连接。我们使用肾脏snRNA-seq分析其病理生理效应。最后,我们对从患者收集的脓毒症组织进行组织学分析,以确保我们在小鼠和人类之间的研究结果具有一致性。
LPS刺激上调了腹腔巨噬细胞中CD38的表达。CD38连接在体内显著加剧了LPS诱导的炎症,尤其是在肾脏中。肾脏snRNA-seq分析显示,CD38连接通过源自CD38阳性巨噬细胞的烟酰胺磷酸核糖转移酶(NAMPT)信号通路诱导肾基质细胞产生白细胞介素(IL)-6。NAMPT抑制显著改善了LPS诱导的IL-6产生和肾损伤。人类脓毒症组织的组织学分析表明,肾基质细胞和CD38阳性巨噬细胞中分别上调了IL6信使RNA和NAMPT。
我们的研究结果阐明了CD38连接在LPS诱导的脓毒症模型中的意义,并揭示了小鼠和人类脓毒症之间共享的信号通路。本研究中确定的NAMPT信号通路可能是减轻与重症脓毒症相关的全身炎症和肾损伤的新治疗靶点。